|
|
|
Weekly Report: Sharekhan Market Commentary
|
|
Friday, November 27, 2015 |
| | | Market Commentary | | | Indices register 1% gain for the Week ahead of RBI policy | | The Indian markets closed with marginal gains and remained in a narrow range in a holiday shortened week. The Sensex rose 1% and the Nifty was up by 1.57% for the week ended Nov 27, 2015. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, November 27, 2015, Indian market rose last week on expectations that the constitutional amendment bill on goods and services tax (GST) will be passed during the winter session of parliament. In this week market was volatile as the November 2015 contracts expired in the futures & options (F&O) segment on Thursday, November 26, 2015. The Sensex settled above the psychological 26,000 mark. The Sensex and the Nifty, both, settled at their highest level in three weeks.
Broad market depicted strength. The BSE Mid-Cap index rose 126.16 points or 1.16% to settle at 10,984.57. The BSE Small-Cap index rose 178.13 points or 1.57% to settle at 11,545.84. Both these indices outperformed the Sensex.
The Sensex rose 259.71 points or 1% to settle at 26,128.20, its highest closing level since 6 November 2015. The Nifty rose 86.15 points or 1.10% to settle at 7,942.70, its highest closing level since 6 November 2015. Weekly market trend from November 23 - November 27, 2015.
Nov 23: Indian stocks edged lower on Monday, swinging between minor gains and losses for most of the session as sentiment turned cautious ahead of the expiry of derivative contracts in a holiday-shortened week. The S&P BSE Sensex and CNX Nifty ended 0.19% and 0.09% lower each.
Nov 24: Indian stocks fell for a second straight session on Tuesday, weighed down by weak European markets and as investors churned positions ahead of the expiry of derivatives contracts this week. The S&P BSE Sensex and CNX Nifty ended 0.17% and 0.22% lower each.
Nov 25: Market was closed on account of Guru Nanak Jayanti.
Nov 26: Indian shares rose on Thursday, snapping a two-session losing streak, helped by auto and energy stocks while hopes parliament would consider a key reform on a goods and services tax also boosted sentiment. The S&P BSE Sensex and CNX Nifty ended 0.71% and 0.67% higher each.
Nov 27: Indian shares edged up on Friday, recording a second straight week of gains, as hopes the  government would look for a compromise with opposition leaders to pass a key reform on goods and services tax (GST) lifted sentiment. The S&P BSE Sensex and CNX Nifty ended 0.65% and 0.75% higher each.
Global indices: Topmost Gainers of the week were: Dax 100 up 1.81%, FTSE 100 up 0.92% and CAC 40 up 0.71%. Topmost Losers of the week were: Shanghai Composite down 5.35%, Hang Seng down 3.02% and Dow Jones down 0.06%.
 Sectoral and stock screening:
Majority of the Sector ended in green, barring S&P BSE HC fell by 0.51% and S&P BSE FMCG fell by 0.33%. Topmost gainers were: S&P BSE Realty rose by 4.37%, S&P BSE Bankex rose by 1.99% and S&P BSE Oil & Gas rose by 1.81%.
| | Looking at the 'A' group stocks, the top three gainers of the week were: MRPL up 20.19%, Gati up 16.43% and Welspun Corp up 14.32%.
Top three losers of the week were: United Spirits down 11.65%, Emami down 8.59% and UPL down 8.01%. FII/MF activity:
The foreign institutional investors (FIIs) have been the net sellers of the Indian stocks to the tune of Rs27.53 crore as on November 23, 2015 and the domestic investors bought Indian shares worth a net of Rs144.10 crore as on November 23, 2015.
| | TOP MOVERS (GROUP A) |  | | | | | | | | | | | | Welspun Corp | 107.80 | 14.32 | | | | | United Spirits | 3,171.30 | -11.65 | | | | | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 3,142.62 | 881.20 | | | Gross sale | 3,170.15 | 737.10 | | | Net investment | -27.53 | 144.10 | | | | | | | | | Data as on November 23, 2015 | | | | Market Outlook for the coming week!
The Reserve Bank of India (RBI) will announce its fifth bi-monthly monetary policy decision at 11:00 IST on Tuesday, December 01, 2015.
In macroeconomic data, the government will release India's gross domestic product (GDP) data for Q2 September 2015 on Monday, November 30, 2015.
The Nikkei India Manufacturing Purchasing Managers' Index (PMI) data for the month of November 2015 is due on Tuesday, December 01, 2015.
The Nikkei India Service PMI data for the month of November 2015 is due on Thursday, December 03, 2015.
Shares of automobile companies will be in focus as companies start announcing monthly sales volume data for November 2015 from Tuesday, December 01, 2015.
Shares of public sector oil marketing companies (PSU OMCs) will be in focus as a regular fuel price review is due at the month end. PSU OMCs review fuel prices twice a month based on the trend in international oil market and currency movement. The first review takes place during the middle of the month and the last review at the month-end. PSU OMCs also review jet fuel prices on the last day of the month.
Shares of aviation firms will be in focus as a regular jet fuel price review is due at the month end. PSU OMCs revise jet fuel prices on the last day of the month based on the average imported oil price in the preceding fortnight. Prices of ATF constitutes approximately 50% of operating expenses of Indian airlines. | | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 11:32 AM  |
|
|
|
|
|
